Instead, a separate winner for each strain is picked in each affected lymph node before immunodominance can come into play.

The system is based on the spread of the primary tumor (t), the extent of lymph node involvement (n), and the presence or absence of metastases (m).

Systemic treatment may benefit some women who have invasive breast cancer without lymph node involvement.